This site is for informational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult your healthcare provider.
A Randomized, Double-Blind, Positive-Controlled, Parallel Pharmacokinetic Phase I Clinical Study of Cetuximab Injection Versus Erbitux in Healthy Male Subjects | MicrobiomeTrials
← Back to trials NCT07813468
A Randomized, Double-Blind, Positive-Controlled, Parallel Pharmacokinetic Phase I Clinical Study of Cetuximab Injection Versus Erbitux in Healthy Male Subjects Recruiting PHASE1 INTERVENTIONAL
Read the full scientific description See full eligibility requirements Trial Details Start: 2026-09-05Est. Completion: 2027-06-30
Enrollment target: 92 participantsLocations Haikou People's Hospital, Haikou, Hainan, China Other microbiome trials you might be interested in Metastatic Colorectal Cancer
To find the recommended dose of ulixertinib that can be given in combination with cetuximab and/or encorafenib to patien…
Houston, United States Est. completion Mar 28, 2028
Colorectal Neoplasms
The main purpose of this study is to evaluate how well olomorasib is tolerated and what side effects may occur when comb…
Multiple Locations Est. completion Nov 2028
Phase 1
Recruiting
TTX-080-001 is a Phase 1, open label, dose escalation and dose expansion clinical study to determine the safety, tolerab…
Tucson, United States Est. completion Jun 1, 2027